News

Royalty Pharma Appoints Vlad Coric, M.D. to the Company’s Board of Directors
Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Vlad Coric, M.D. to the company’s Board of Directors, effective immediately. Vlad Coric is the Chairman and Chief Executive Officer ...
Royalty Pharma appoints Biohaven CEO Vlad Coric to board
Royalty Pharma (RPRX) announced the appointment of Vlad Coric to the company’s board of directors, effective immediately. Vlad Coric is the ...
Investor's Business Daily on MSN1mon
Biohaven Slumps, Again, As Bipolar Setback Outweighs A $4 Billion Opportunity
Biohaven stock tumbled for the second day running Tuesday after its bipolar mania treatment failed in a three-week study. Analysts called the stock reaction overdone, while Chief Executive Vlad ...
Yale Environment 3609d
Bridge builders: Awards celebrate those who strengthen the bond between Yale and New Haven
Recipients of the Elm Awards were Carolyn Baker and Diane Petaway, co-presidents of the Greater New Haven African American Historical Society who have developed an array of community programs ...
Hosted on MSN2mon
Deutsche Bank sets $65 target for Biohaven stock with Buy rating
The firm's analysts cited the leadership of CEO Vlad Coric and the company's potential for steady value creation as key factors in their positive outlook. According to InvestingPro data ...
Yahoo Finance10d
Royalty Pharma Appoints Vlad Coric, M.D. to the Company’s Board of Directors
NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Vlad Coric, M.D. to the company’s Board of Directors, effective immediately.
manilatimes9d
Royalty Pharma Appoints Vlad Coric, M.D. to the Company's Board of Directors
NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Vlad Coric, M.D. to the company's Board of Directors, effective immediately. Vlad ...